Three hundred and thirty leprosy patients were examined for BCG scars. Out of them 72 patients had BCG scars. Of these 72 patients, 68% developed tuberculoid, 5. 35% borderline and 13.9% lepromatous leprosy. Two hundred fifty eight patients had no BCG scars. Of these, 62.4% developed tuberculoid, 20.9% borderline and 12.4% lepromatous leprosy. These findings suggest that BCG vaccination does not appear to protect patients from, developing leprosy.